As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
AABB Celebrates World Cord Blood Day, Officially Welcomes CBA Members
November 19, 2025
FDA Adds Boxed Warning for Sarepta’s DMD Gene Therapy
November 17, 2025
StemCyte Introduces Insurance-Linked Cord Blood Access in Taiwan
November 12, 2025